AT388377B - 7-((m-subst.)-phenylglycin)-1-carba-1dethiacephalosporine - Google Patents

7-((m-subst.)-phenylglycin)-1-carba-1dethiacephalosporine

Info

Publication number
AT388377B
AT388377B AT0257587A AT257587A AT388377B AT 388377 B AT388377 B AT 388377B AT 0257587 A AT0257587 A AT 0257587A AT 257587 A AT257587 A AT 257587A AT 388377 B AT388377 B AT 388377B
Authority
AT
Austria
Prior art keywords
phenylglycin
carba
subst
chem
pharmaceutically
Prior art date
Application number
AT0257587A
Other languages
English (en)
Other versions
ATA257587A (de
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ATA257587A publication Critical patent/ATA257587A/de
Application granted granted Critical
Publication of AT388377B publication Critical patent/AT388377B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D463/00Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16Nitrogen atoms
    • C07D463/18Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cephalosporin Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT0257587A 1986-10-03 1987-10-08 7-((m-subst.)-phenylglycin)-1-carba-1dethiacephalosporine AT388377B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91517386A 1986-10-03 1986-10-03

Publications (2)

Publication Number Publication Date
ATA257587A ATA257587A (de) 1988-11-15
AT388377B true AT388377B (de) 1989-06-12

Family

ID=25435354

Family Applications (2)

Application Number Title Priority Date Filing Date
AT87308713T ATE79119T1 (de) 1986-10-03 1987-10-01 7-((meta-substituiert)-phenylglycin>-1-carba-1dethia-cephalosporine.
AT0257587A AT388377B (de) 1986-10-03 1987-10-08 7-((m-subst.)-phenylglycin)-1-carba-1dethiacephalosporine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT87308713T ATE79119T1 (de) 1986-10-03 1987-10-01 7-((meta-substituiert)-phenylglycin>-1-carba-1dethia-cephalosporine.

Country Status (17)

Country Link
EP (1) EP0266896B1 (de)
JP (1) JPS6396186A (de)
KR (1) KR880005125A (de)
CN (1) CN87107149A (de)
AT (2) ATE79119T1 (de)
BG (1) BG47034A3 (de)
DE (1) DE3780909T2 (de)
DK (1) DK518487A (de)
FI (1) FI874311A (de)
GR (1) GR3005920T3 (de)
HU (1) HU200179B (de)
IE (1) IE872646L (de)
IL (1) IL84051A0 (de)
NZ (1) NZ222015A (de)
PL (1) PL151703B1 (de)
PT (1) PT85850B (de)
ZA (1) ZA877398B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA89829B (en) * 1988-02-05 1990-10-31 Lilly Co Eli Crystalline b-lactam solvate
CA2442219C (en) 2001-03-28 2007-09-11 Schering Corporation Enantioselective synthesis of azetidinone intermediate compounds
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
AU2003298513A1 (en) * 2002-05-14 2004-05-13 Northwestern University STERICALLY-AWKWARD Beta-LACTAMASE INHIBITORS
ATE406364T1 (de) 2003-03-07 2008-09-15 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
ES2318274T3 (es) 2003-03-07 2009-05-01 Schering Corporation Compuestos de azetidinona sustituida, formulaciones y uso de los mismos para el tratamiento de hipercolesterolemia.
CN102144992B (zh) * 2011-03-10 2013-04-10 浙江大学 苯基甘氨酸衍生物制备对金黄色葡萄球菌有抑菌和杀菌活性的抗菌剂的用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014476A1 (de) * 1979-02-10 1980-08-20 Kyowa Hakko Kogyo Co., Ltd Optisch aktive acylierte cephalosporinähnliche Verbindungen, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
US4335211A (en) * 1979-11-14 1982-06-15 Kyowa Hakko Kogyo Co., Ltd. Process for producing optically active cephalosporin analogs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697515A (en) * 1963-02-18 1972-10-10 Ciba Geigy Corp Process for splitting the 7-n-acyl group from cephalosporin compounds
NO155547C (no) * 1979-02-10 1987-04-15 Kyowa Hakko Kogyo Kk Optisk aktive cefalosporin-analoge og salter derav samt fremgangsmaate for deres fremstilling.
JPS60174787A (ja) * 1984-02-21 1985-09-09 Kyowa Hakko Kogyo Co Ltd 3位置換カルバセフエム化合物
US4673737A (en) * 1985-08-02 1987-06-16 Harvard University 7-acylamino-(or 7-amino)-3-trifluoromethylsulfonyloxy-1-carba(1-dethia)-3-cephem-4-carboxylic acids and esters thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014476A1 (de) * 1979-02-10 1980-08-20 Kyowa Hakko Kogyo Co., Ltd Optisch aktive acylierte cephalosporinähnliche Verbindungen, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
US4335211A (en) * 1979-11-14 1982-06-15 Kyowa Hakko Kogyo Co., Ltd. Process for producing optically active cephalosporin analogs

Also Published As

Publication number Publication date
IE872646L (en) 1988-04-03
FI874311A (fi) 1988-04-04
DK518487D0 (da) 1987-10-02
KR880005125A (ko) 1988-06-28
AU7926987A (en) 1988-04-14
EP0266896A1 (de) 1988-05-11
AU591811B2 (en) 1989-12-14
ATA257587A (de) 1988-11-15
PL268034A1 (en) 1988-09-01
CN87107149A (zh) 1988-05-18
ZA877398B (en) 1989-05-30
GR3005920T3 (de) 1993-06-07
NZ222015A (en) 1989-10-27
JPS6396186A (ja) 1988-04-27
IL84051A0 (en) 1988-03-31
PL151703B1 (en) 1990-09-28
EP0266896B1 (de) 1992-08-05
DK518487A (da) 1988-04-04
FI874311A0 (fi) 1987-10-01
BG47034A3 (en) 1990-04-16
DE3780909T2 (de) 1993-03-04
HUT45053A (en) 1988-05-30
PT85850A (en) 1987-11-01
ATE79119T1 (de) 1992-08-15
DE3780909D1 (en) 1992-09-10
HU200179B (en) 1990-04-28
PT85850B (en) 1990-01-12

Similar Documents

Publication Publication Date Title
FI852974L (fi) Nya n-hydroxylgruppen skyddande grupper och framstaellningsfoerfarande foer 3-acylamino-1-hydroxi-2-azetidinoner.
SE8601907L (sv) Antitrombogena och kardiotoniska imidazokinoliner
IL64288A0 (en) Improvements relating to 3-aryloxy-3-phenylpropylamines
ATE24001T1 (de) Substituierte 1-hydroxyethyl-triazolyl-derivate.
DE3772015D1 (de) Chinolinverbindung.
DK506587D0 (da) Imidderivater
FI861506A0 (fi) Foerfarande foer framstaellning av 1,2-ditiolan-3-pentansyra (tioktsyra).
DE69131090D1 (de) Heteroaroylderivate von monocyclischen Beta-lactam-Antibiotika
AT388377B (de) 7-((m-subst.)-phenylglycin)-1-carba-1dethiacephalosporine
ATE85978T1 (de) 2-quaternaer-pyridinalkylthio- oder pyridinalkenylthiosubstituierte carbapeneme, diese enthaltende zusammensetzungen und ihre zusammenstellungen mit dhp-inhibitoren.
FR2361351A1 (fr) Intermediaires de preparation d'homologues de somatostatine
ES2036682T3 (es) Un procedimiento para preparar un derivado de tiofeno.
FI903967A0 (fi) Nya imidazolderivat.
DE3374124D1 (de) 5-phenylethenylbenzimidazoles
DK439286D0 (da) Propanolderivater
SE8704551D0 (sv) New benzo(g)quinolines
FR2359836A1 (fr) Ethers de zearaline utiles comme agents promoteurs de la croissance
ATE18757T1 (de) 9,10-bis-(phenylaethinyl)-anthracene.